Dr. Stuart J. Wong, MD
Claim this profileMedical College of Wisconsin
Studies Squamous Cell Carcinoma
Studies Cancer
13 reported clinical trials
25 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
p16 positive
Stage II
2Cancer
p16 positive
Stage IV
p16 negative
Affiliated Hospitals
Clinical Trials Stuart J. Wong, MD is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Anti-tumor B
for Cancer
This is a window of opportunity study of Anti-tumor B (ATB). Anti-tumor B is a botanical agent composed of six Chinese herbs: Sophora tonkinensis, Polygonum bistorta, Prunella vulgaris, Sonchus brachyotus, Dictamnus dasycarpus, and Dioscorea bulbifera.
Recruiting1 award Phase < 111 criteria
More about Stuart J. Wong, MD
Clinical Trial Related6 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Stuart J. Wong, MD has experience with
- Cisplatin
- Pembrolizumab
- Nivolumab
- Carboplatin
- Docetaxel
- Intensity-Modulated Radiation Therapy
Breakdown of trials Stuart J. Wong, MD has run
Squamous Cell Carcinoma
Cancer
Head and Neck Squamous Cell Carcinoma
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stuart J. Wong, MD specialize in?
Stuart J. Wong, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are p16 positive.
Is Stuart J. Wong, MD currently recruiting for clinical trials?
Yes, Stuart J. Wong, MD is currently recruiting for 8 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Stuart J. Wong, MD has studied deeply?
Yes, Stuart J. Wong, MD has studied treatments such as Cisplatin, Pembrolizumab, Nivolumab.
What is the best way to schedule an appointment with Stuart J. Wong, MD?
Apply for one of the trials that Stuart J. Wong, MD is conducting.
What is the office address of Stuart J. Wong, MD?
The office of Stuart J. Wong, MD is located at: Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.